Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?

The Journal of Clinical Investigation
Dennis W Dickson

Abstract

Increasing evidence suggests that selective neuronal loss in neurodegenerative diseases involves activation of cysteine aspartyl proteases (caspases), which initiate and execute apoptosis. In Alzheimer disease both extracellular amyloid deposits and intracellular amyloid beta protein may activate caspases, leading to cleavage of nuclear and cytoskeletal proteins, including tau protein. Proteolysis of tau may be critical to neurofibrillary degeneration, which correlates with dementia.

References

Sep 29, 1989·Biochemical and Biophysical Research Communications·G V JohnsonL I Binder
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·C M WischikA Klug
Nov 1, 1994·Journal of Neuropathology and Experimental Neurology·A MigheliD Schiffer
Feb 1, 1995·Molecular Neurobiology·C W Cotman, A J Anderson
Apr 1, 1997·Journal of Neuropathology and Experimental Neurology·D W Dickson
May 22, 1998·Journal of Neuropathology and Experimental Neurology·C StadelmannH Lassmann
Sep 23, 1998·Experimental Neurology·M P MattsonJ G Begley
Oct 12, 1999·Brain Pathology·S H YenP Nacharaju
Jan 13, 2000·Trends in Neurosciences·K K Wang
Feb 16, 2000·Neurobiology of Aging·E GroberR B Lipton
Oct 31, 2001·Neuron·R E Tanzi, L Bertram
Jan 31, 2002·Journal of Molecular Neuroscience : MN·C Glabe
Jun 27, 2002·Proceedings of the National Academy of Sciences of the United States of America·Michael K LeeDon L Price
Jul 2, 2003·Seminars in Arthritis and Rheumatism·Duane R Schultz, William J Harrington
Jul 31, 2003·Proceedings of the National Academy of Sciences of the United States of America·T Chris GamblinVincent L Cryns
Aug 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yuesong GongWilliam L Klein
Dec 4, 2003·Neurobiology of Aging·E-M MandelkowE Mandelkow

❮ Previous
Next ❯

Citations

May 16, 2008·Marine Biotechnology·Razi Vago
Dec 18, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Geeta S ParanjapeMichael R Nichols
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Hong-Lian LiJian-Zhi Wang
Apr 30, 2010·Rejuvenation Research·Svetlana V UkraintsevaAnatoli I Yashin
Aug 17, 2006·Journal of Virology·Jason M GraysonDavid Hildeman
Mar 12, 2013·TheScientificWorldJournal·Benoît Leclerc, Abedelnasser Abulrob
Sep 24, 2008·Clinical and Molecular Allergy : CMA·Erick FornoJuan C Celedón
Sep 5, 2008·PloS One·Debra ToiberHermona Soreq
Mar 28, 2008·Molecular Medicine·Rita M RamalhoCecília M P Rodrigues
Jul 10, 2010·The International Journal of Neuroscience·M Obulesu, Dowlathabad Muralidhara Rao
Jul 21, 2009·Brain Research Bulletin·Natasa Bulat, Christian Widmann
Jun 11, 2009·Communicative & Integrative Biology·P CalissanoG Amadoro
Mar 20, 2014·The International Journal of Neuropsychopharmacology·Xiaolei ZhuYun Xu
Mar 26, 2016·Archives of Biochemistry and Biophysics·Shana E Terrill-UseryMichael R Nichols
May 16, 2006·Neurobiology of Aging·João Carlos SousaJoana Almeida Palha
Jan 19, 2006·Neurochemistry International·Mariko Tsukane, Takashi Yamauchi
Nov 7, 2006·Biochimica Et Biophysica Acta·Elena I Posse de Chaves
Jan 13, 2009·Archives of Biochemistry and Biophysics·M PellicanòM Di Carlo
Jan 26, 2008·Journal of Peptide Science : an Official Publication of the European Peptide Society·Yann VerdierBotond Penke
Feb 13, 2009·Journal of Cellular and Molecular Medicine·Jin-Jing Pei, Jacques Hugon
May 10, 2006·Genes, Brain, and Behavior·M GrazinaC Oliveira
Sep 5, 2006·Apoptosis : an International Journal on Programmed Cell Death·Ozgur Kutuk, Huveyda Basaga
Jan 27, 2010·The Mount Sinai Journal of Medicine, New York·Maria Jose Metcalfe, Maria E Figueiredo-Pereira
Jul 22, 2010·Journal of Neuroscience Research·Mami YamaguchiHitoshi Sohma
Sep 28, 2005·Neurochemical Research·Debra Toiber, Hermona Soreq
Mar 2, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Dara L DicksteinWilfred A Jefferies
May 19, 2012·Nature Reviews. Neuroscience·Bradley T Hyman, Junying Yuan
Apr 9, 2019·Cell Biology International·Mark S D'Arcy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis